Since only a small fraction of cases occur in premenopausal women it is suggested that screening be limited to postmenopausal women.
US preventive services task force recommendation is against ovarian cancer screening for asymptomatic women.
It is found at present ovarian cancer screening is of no value, and has potential for harm, anxiety, and unnecessary invasive diagnostic testing.